MT
Mivax Therapeutics, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$108Ksold at filing
Total offering$500K$393K still open
Investors in the raise21count reported to the SEC
FiledJan 23, 2026first sale Apr 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Viraj Balkrishna DeshpandeExecutive Officer
Pragyesh Balkrishna DhungelExecutive Officer
Executive officers, directors and promoters as listed on the Form D.